[{"Assets_0_Q1_USD":26119200000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":1467300000.0,"NetIncomeLossConverted_1_Q1_USD":1392600000.0,"RevenuesConverted_1_Q1_USD":3534300000.0,"StockholdersEquity_0_Q1_USD":12546900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":173100000.0,"StockholdersEquityConverted_0_Q1_USD":12536900000.0,"EarningsPerShareBasic_1_Q1_USD":8.1,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":172800000.0,"EarningsPerShareDiluted_1_Q1_USD":8.08,"Ticker":"BIIB","CIK":"875045","name":"BIOGEN INC.","OfficialName":"Biogen Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"32775642095.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20200423"}]